Abstract
Among the extended-spectrum β-lactamase (ESBL)-producing Klebsiella pneumoniae and Escherichia coli, 3.9% of K. pneumoniae showed nonsusceptibility to imipenem or meropenem; and their mechanism was the combination of ESBL and/or plasmid-mediated AmpC β-lactamase production and porin loss. The presence of bla CTX-M-14 and loss of OmpK36 were associated with higher carbapenem MICs.
| Original language | English |
|---|---|
| Pages (from-to) | 87-89 |
| Number of pages | 3 |
| Journal | Diagnostic Microbiology and Infectious Disease |
| Volume | 71 |
| Issue number | 1 |
| DOIs | |
| State | Published - Sep 2011 |
Bibliographical note
Funding Information:We wish to thank all the contributing laboratories that provided isolates for this study. This work was supported by a research grant from the Korea Center for Disease Control (2009-E00520-00).
UN SDGs
This output contributes to the following UN Sustainable Development Goals (SDGs)
-
SDG 3 Good Health and Well-being
Keywords
- BlaCTX-M-14
- Carbapenem
- OmpK36
Fingerprint
Dive into the research topics of 'Prevalence and contributing factors of nonsusceptibility to imipenem or meropenem in extended-spectrum β-lactamase-producing Klebsiella pneumoniae and Escherichia coli'. Together they form a unique fingerprint.Cite this
- APA
- Author
- BIBTEX
- Harvard
- Standard
- RIS
- Vancouver